Boxer Capital Management, LLC Top Holdings and 13F Report (2025) About Boxer Capital Management, LLCInvestment ActivityBoxer Capital Management, LLC has $198.66 million in total holdings as of June 30, 2025.Boxer Capital Management, LLC owns shares of 20 different stocks, but just 8 companies or ETFs make up 80% of its holdings.Approximately 22.52% of the portfolio was purchased this quarter.About 120.63% of the portfolio was sold this quarter.This quarter, Boxer Capital Management, LLC has purchased 28 new stocks and bought additional shares in 3 stocks.Boxer Capital Management, LLC sold shares of 7 stocks and completely divested from 16 stocks this quarter.Largest Holdings Tango Therapeutics $50,030,003Revolution Medicines $29,173,624Replimune Group $20,543,358Merus $19,199,000Kymera Therapeutics $18,852,916 Largest New Holdings this Quarter 46565G104 - iTeos Therapeutics $8,225,250 HoldingM96088105 - Urogen Pharma $7,877,500 HoldingG2545C104 - CRESCENT BIOPHARMA INC. $7,322,492 Holding74366E102 - Protagonist Therapeutics $3,316,200 Holding640268306 - NEKTAR THERAPEUTICS $3,230,000 Holding Largest Purchases this Quarter iTeos Therapeutics 825,000 shares (about $8.23M)Urogen Pharma 575,000 shares (about $7.88M)CRESCENT BIOPHARMA INC. 453,686 shares (about $7.32M)Kymera Therapeutics 107,010 shares (about $4.67M)Replimune Group 415,000 shares (about $3.86M) Largest Sales this Quarter Revolution Medicines 525,000 shares (about $19.31M)Merus 335,000 shares (about $17.62M)Nurix Therapeutics 388,067 shares (about $4.42M)Amylyx Pharmaceuticals 525,000 shares (about $3.37M)Tango Therapeutics 609,514 shares (about $3.12M) Sector Allocation Over TimeMap of 500 Largest Holdings ofBoxer Capital Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorTNGXTango Therapeutics$50,030,003$3,120,712 ▼-5.9%9,771,48525.2%MedicalRVMDRevolution Medicines$29,173,624$19,314,750 ▼-39.8%792,97714.7%MedicalREPLReplimune Group$20,543,358$3,855,350 ▲23.1%2,211,34110.3%MedicalMRUSMerus$19,199,000$17,621,000 ▼-47.9%365,0009.7%MedicalKYMRKymera Therapeutics$18,852,916$4,669,916 ▲32.9%432,0109.5%MedicalQUREuniQure$12,539,030$2,084,030 ▲19.9%899,5006.3%MedicalITOSiTeos Therapeutics$8,225,250$8,225,250 ▲New Holding825,0004.1%MedicalURGNUrogen Pharma$7,877,500$7,877,500 ▲New Holding575,0004.0%MedicalAMLXAmylyx Pharmaceuticals$7,852,250$3,365,250 ▼-30.0%1,225,0004.0%MedicalCRESCENT BIOPHARMA INC.$7,322,492$7,322,492 ▲New Holding453,6863.7%COMPTGXProtagonist Therapeutics$3,316,200$3,316,200 ▲New Holding60,0001.7%MedicalNEKTAR THERAPEUTICS$3,230,000$3,230,000 ▲New Holding125,0001.6%COM NEWKODKodiak Sciences$2,797,500$1,063,050 ▼-27.5%750,0001.4%MedicalCIDARA THERAPEUTICS INC$2,679,050$2,679,050 ▲New Holding55,0001.3%COM NEWNRIXNurix Therapeutics$1,993,250$4,420,083 ▼-68.9%175,0001.0%MedicalINSTIL BIO INC$1,472,681$196,323 ▼-11.8%70,7000.7%COM NEWKALVKalVista Pharmaceuticals$1,055,887$1,055,887 ▲New Holding93,4000.5%MedicalSRPTSarepta Therapeutics$427,500$427,500 ▲New Holding25,0000.2%MedicalNUVATION BIO INC$71,9730.0%266,6660.0%*W EXP 02/10/202SRZNWSurrozen$1,2070.0%66,6660.0%MedicalNUVLNuvalent$0$31,914,000 ▼-100.0%00.0%MedicalRNAAvidity Biosciences$0$25,534,800 ▼-100.0%00.0%MedicalANABAnaptysBio$0$24,167,000 ▼-100.0%00.0%MedicalXENEXenon Pharmaceuticals$0$20,130,000 ▼-100.0%00.0%MedicalAPLSApellis Pharmaceuticals$0$15,593,310 ▼-100.0%00.0%MedicalCMRXChimerix$0$15,403,100 ▼-100.0%00.0%MedicalELVNEnliven Therapeutics$0$13,212,325 ▼-100.0%00.0%MedicalORICOric Pharmaceuticals$0$9,667,746 ▼-100.0%00.0%MedicalDAWNDay One Biopharmaceuticals$0$9,436,248 ▼-100.0%00.0%MedicalPRTAProthena$0$8,538,750 ▼-100.0%00.0%MedicalLEGNLegend Biotech$0$6,786,000 ▼-100.0%00.0%MedicalSLDBSolid Biosciences$0$4,590,590 ▼-100.0%00.0%MedicalDNLIDenali Therapeutics$0$3,400,000 ▼-100.0%00.0%MedicalPRLDPrelude Therapeutics$0$1,623,171 ▼-100.0%00.0%MedicalBOUNDLESS BIO INC$0$377,500 ▼-100.0%00.0%COMELYMEliem Therapeutics$0$176,900 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access